Zura Bio director Someit Sidhu resigns from board
Zura Bio Limited reported a board change.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Zura Bio Limited reported a board change. On May 20, 2026, director Someit Sidhu informed the company that he will resign from the board of directors, effective May 21, 2026. The company states that his resignation is not due to any disagreement regarding its operations, policies or practices.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Notification date: May 20, 2026
Resignation effective date: May 21, 2026
Share par value: $0.0001 per share
+1 more
4 metrics
Notification date
May 20, 2026
Date director informed Zura Bio of resignation
Resignation effective date
May 21, 2026
Effective date of Someit Sidhu’s board resignation
Share par value
$0.0001 per share
Par value of Class A ordinary shares listed on Nasdaq
Company address
1489 W. Warm Springs Rd. #110
Principal executive offices in Henderson, NV 89014
Key Terms
Emerging growth company, Item 5.02, Securities Exchange Act of 1934, Nasdaq Stock Market
4 terms
Emerging growth company regulatory
"Emerging growth company x"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Item 5.02 regulatory
"Item 5.02 Departure of Directors or Certain Officers"
Item 5.02 is a specific disclosure category on the U.S. Securities and Exchange Commission’s Form 8‑K that requires public companies to report changes in key personnel and related compensation arrangements. It covers departures and appointments of directors and certain officers, elections of directors, and new or material changes to compensatory agreements for those persons; the company must file a Form 8‑K with the required information and any related exhibits within the SEC’s prescribed reporting timeframe. The item is a rule‑based reporting obligation under U.S. securities law, so its scope and timing follow the SEC’s definitions and deadlines rather than informal usage.
Securities Exchange Act of 1934 regulatory
"pursuant to the requirements of the Securities Exchange Act of 1934"
Nasdaq Stock Market market
"ZURA | | The Nasdaq Stock Market"
The Nasdaq Stock Market is a place where many companies' shares are bought and sold, functioning like a marketplace for investing in businesses. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping people grow their wealth or fund business growth. Known for hosting many technology and innovative companies, it is a key indicator of the health of those sectors.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board change did ZURA disclose in this 8-K filing?
Zura Bio Limited disclosed that director Someit Sidhu resigned from its board of directors effective May 21, 2026. The company states the resignation is not due to any disagreement regarding operations, policies, or practices.
When is Someit Sidhu’s resignation from ZURA’s board effective?
His resignation from Zura Bio Limited’s board is effective on May 21, 2026. He notified the company of his decision on May 20, 2026, providing one day’s notice before the effective date.
Did Zura Bio indicate any disagreement behind the director’s resignation?
Zura Bio states that Someit Sidhu’s resignation is not due to any disagreement with the company. This covers matters relating to its operations, corporate policies, or business practices according to the disclosure language.
Which SEC item does Zura Bio use to report the director resignation?
Zura Bio reports the resignation under Item 5.02, which covers departures or appointments of directors and certain officers. This item also includes compensatory arrangements, although none are described in the provided excerpt.
AI-generated analysis. How Rhea-AI works. Not financial advice.
